title: Improvement in stroke quality management by an educational programme.
abstract: Time after symptom onset in ischaemic stroke has to be as short as possible to increase success of treatment. We prospectively analysed latencies from symptom onset until the start of therapy and the rate of thrombolysis in 196 patients with suspected stroke sequentially admitted to the hospital before (6 weeks prior, n = 83) and after (n = 113) initiating an educational stroke programme (EP). A total of 345 dispatchers, paramedics, and emergency staff were trained, each person for at least 2 h. The mean pre-hospital time interval from symptom onset until admission was significantly decreased by nearly 2 h (p < 0.05). Thrombolytic therapy frequencies increased from 2 to 10.5% (p < 0.01) because the overall mean time interval from admission to the start of therapy significantly decreased (p < 0.01) by 69 min after the EP, with increasing numbers of patients suitable for acute stroke therapies within a 0- to 3-hour treatment window.
authors: Department of Neurology, University of Heidelberg, Universitätsklinikum Mannheim, Germany.
authors: Stephan
authors: S
authors: Behrens
authors: Michael
authors: M
authors: Daffertshofer
authors: Cordula
authors: C
authors: Interthal
authors: Klaus
authors: K
authors: Ellinger
authors: Klaus
authors: K
authors: van Ackern
authors: Michael
authors: M
authors: Hennerici
mesh_terms: D000368:Aged; D002543:Cerebral Hemorrhage / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D017598:Efficiency, Organizational; D004632:Emergency Medical Services; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D002546:Ischemic Attack, Transient / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D008297:Male; D010343:Patient Admission; D010353:Patient Education as Topic; D011787:Quality of Health Care; D020521:Stroke / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014504:Urban Health
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator